Protocol - Perception of Tobacco Product Harm - Cigarettes
- Perceived Harm of Substance Use
- Perception of Tobacco Product Harm - Cigars
- Perception of Tobacco Product Harm - E-Cigarettes
- Perception of Tobacco Product Harm - Pipe Tobacco
- Perception of Tobacco Product Harm - Smokeless Tobacco
Description
This protocol includes questions from Wave 3 of the Adult Population Assessment of Tobacco and Health Study survey instrument. These specific questions are used to measure a respondent’s perception about the perceived harm of smoking cigarettes. The three response categories range from less harmful to more harmful.
Specific Instructions
The Smoking Cessation, Harm Reduction, and Biomarkers Working Group recommends categorizing respondents based on the following reported use characteristics, according to the Use of Tobacco Products protocol: (1) ever user versus never user; (2) current established user, defined as everyday user or some-day user; and (3) former established user. Polyuse with other tobacco products should be considered as well.
Current and former users might also be categorized based on type of cigarette smoked: menthol flavor or nonmenthol flavor.
The Smoking Cessation, Harm Reduction, and Biomarkers Working Group also suggests questions 2 and 3 be considered to get at brand descriptors that might modify cigarette harm perceptions.
Availability
Protocol
1. Do you think the brand of cigarettes you [usually smoke | usually smoked | last smoked] might be less harmful, no different, or more harmful, compared to other cigarette brands?
[ ] 1 Less harmful
[ ] 2 No different
[ ] 3 More harmful
[ ] -8 DONT KNOW
[ ] -7 REFUSED
2. Do you think a tobacco product described as additive-free is less harmful, about the same, or more harmful than a regular tobacco product?
[ ] 1 Less harmful
[ ] 2 About the same
[ ] 3 More harmful
[ ] -8 DONT KNOW
[ ] -7 REFUSED
ASK: All adult respondents.
3. Do you think a tobacco product described as organic is less harmful, about the same, or more harmful than a regular tobacco product?
[ ] 1 Less harmful
[ ] 2 About the same
[ ] 3 More harmful
[ ] -8 DONT KNOW
[ ] -7 REFUSED
ASK: All adult respondents.
Personnel and Training Required
None
Equipment Needs
The PhenX Working Group acknowledges that these questions can be administered in a computerized or noncomputerized format (i.e., paper-and-pencil instrument). Computer software is necessary to develop computer-assisted instruments. The interviewer will require a laptop computer/handheld computer to administer a computer-assisted questionnaire.
Requirements
| Requirement Category | Required |
|---|---|
| Major equipment | No |
| Specialized training | No |
| Specialized requirements for biospecimen collection | No |
| Average time of greater than 15 minutes in an unaffected individual | No |
Mode of Administration
Interviewer-administered questionnaire
Lifestage
Adolescent, Adult
Participants
Adult (aged 18 or older)
Adolescent (aged 12-17)
Selection Rationale
The Population Assessment of Tobacco and Health (PATH) Study is a nationally representative, in-person longitudinal cohort study of nonusers and users of tobacco products and those at risk for tobacco use across the United States. Respondents aged 12 years or older are asked questions on tobacco use, attitudes, and health, and biospecimens (buccal cell, urine, and blood) are collected from adults. The PATH Study was implemented to provide an evidence base for assessing and monitoring the U.S. Food and Drug Administrations regulatory actions in meeting its mandate under the Family Smoking Prevention and Tobacco Control Act. Regulatory domains include product standards, new and modified risk products, health warnings, and health education campaigns.
Language
English, Spanish
Standards
| Standard | Name | ID | Source |
|---|---|---|---|
| Human Phenotype Ontology | Addictive behavior | HP:0030858 | HPO |
Derived Variables
None
Process and Review
Not Applicable
Protocol Name from Source
Population Assessment of Tobacco and Health (PATH) Study, PATH Wave 3 Adult Annotated Instrument, 2018
Source
U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse; and U.S. Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Products, Population Assessment of Tobacco and Health (PATH) Study, 2018, Wave 3 Adult Annotated Instrument, items AC9019, AX0723, AX0724. Distributed October 21, 2020, by Inter-university Consortium for Political and Social Research, Ann Arbor, MI.
General References
Elton-Marshall, T., Driezen, P., Fong, G. T., Cummings, K. M., Persoskie, A., Wackowski, O., Choi, K., Kaufman, A., Strong, D., Gravely, S., Taylor, K., Kwan, J., Bansal-Travers, M., Travers, M., & Hyland, A. (2020). Adult perceptions of the relative harm of tobacco products and subsequent tobacco product use: Longitudinal findings from waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study. Addictive Behaviors, 106, 106337.
Fong, G. T., Elton-Marshall, T., Driezen, P., Kaufman, A. R., Cummings, K. M., Choi, K., Kwan, J., Koblitz, A., Hyland, A., Bansal-Travers, M., Carusi, C., & Thompson, M. E. (2019). U.S. adult perceptions of the harmfulness of tobacco products: descriptive findings from the 2013-14 baseline wave 1 of the PATH Study. Addictive Behaviors, 91, 180-187.
Leas, E. C., Ayers, J. W., Strong, D. R., & Pierce, J. P. (2017). Which cigarettes do Americans think are safer? A population-based analysis with wave 1 of the PATH Study. Tobacco Control, 26(e1), e59-e60.
Pearson, J. L., Johnson, A., Villanti, A., Glasser, A. M., Collins, L., Cohn, A., Rose, S. W., Niaura, R., & Stanton, C. A. (2017). Misperceptions of harm among Natural American Spirit smokers: Results from wave 1 of the Population Assessment of Tobacco and Health (PATH) Study (2013-2014). Tobacco Control, 26(e1), e61-e67.
Protocol ID
330501
Variables
Export Variables| Variable Name | Variable ID | Variable Description | dbGaP Mapping | |
|---|---|---|---|---|
| PX330501_Perception_Risk_Cigarettes_Additive_Free_Harmful | ||||
| PX330501020000 | Do you think a tobacco product described as more | N/A | ||
| PX330501_Perception_Risk_Cigarettes_Brand_Harmful | ||||
| PX330501010000 | Do you think the brand of cigarettes you more | N/A | ||
| PX330501_Perception_Risk_Cigarettes_Organic_Harmful | ||||
| PX330501030000 | Do you think a tobacco product described as more | N/A | ||
Measure Name
Perception of Tobacco Product Harm
Release Date
February 23, 2021
Definition
Instrument used to assess respondents' perception of how much they think people risk harming themselves by using tobacco products and of the relative harm between low-risk products and combustible cigarettes.
Purpose
The purpose of this measure is to collect information from respondents on their thoughts about the physical and health harms associated with using tobacco products. Perceptions of harm of tobacco products are important in predicting first use and continued use.
Keywords
Perceived harm, product harm, Population Assessment of Tobacco and Health, PATH, National Institutes of Health, NIH, U.S. Food and Drug Administration, FDA, Smoking Cessation, Harm Reduction, and Biomarkers, cigarettes, tobacco
Measure Protocols
| Protocol ID | Protocol Name |
|---|---|
| 330501 | Perception of Tobacco Product Harm - Cigarettes |
| 330502 | Perception of Tobacco Product Harm - E-Cigarettes |
| 330503 | Perception of Tobacco Product Harm - Cigars |
| 330504 | Perception of Tobacco Product Harm - Pipe Tobacco |
| 330505 | Perception of Tobacco Product Harm - Smokeless Tobacco |
Publications
There are no publications listed for this protocol.